Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- TOPICS 2 articles
July 28, 2008
- R&D NEWS IN BRIEF
July 28, 2008
- Vildagliptin More Effective than Voglibose
July 28, 2008
- REGULATORY NEWS IN BRIEF －２－
July 28, 2008
- REGULATORY NEWS IN BRIEF －１－
July 28, 2008
- R&D NEWS IN BRIEF
July 21, 2008
- Ranbaxy Categorically Denies Allegations
July 21, 2008
- Korosho Gives Up Development of 2 Unapproved Drugs
July 21, 2008
- Nippon Kayaku to Actively Invest in Macromolecular Anticancer Agents
July 21, 2008
- Korosho Calls For Commercialization of Cures of Alzheimer's Disease in 10 Years
July 21, 2008
- Ferring Accelerates Business Development in Japan Aiming at \30 Bil. Sales in 2017
July 21, 2008
- Daiichi Sankyo to Collaborate with Seattle Genetics to Develop ADC Drugs
July 21, 2008
- Daiichi Sankyo Enters \88 Bil. Market for NSAID Tapes with Loxonin
July 21, 2008
- Kyowa Hakko Starts Developing siRNA Drugs in Earnest
July 21, 2008
- MEDICAL DEVICE NEWS IN BRIEF
July 21, 2008
- REGULATORY NEWS IN BRIEF
July 21, 2008
- Korosho Takes into Account US Opposition to More Frequent Drug Price Revisions
July 21, 2008
- Use of Tamiflu Not Correlated with Abnormal Behavior: Korosho Working Group
July 21, 2008
- Chuikyo to Conduct Survey to Verify Effects of FY2008 Medical Fee Revision
July 21, 2008
- Switch OTC Drugs Hold Key to Market Revitalization
July 21, 2008
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…